By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Miscellaneous antibiotics > Lampit > Lampit Dosage
Miscellaneous antibiotics
https://themeditary.com/dosage-information/lampit-dosage-5166.html

Lampit Dosage

Drug Detail:Lampit (Nifurtimox [ nye-fure-ti-mox ])

Generic Name: NIFURTIMOX 30mg

Dosage Form: tablet, film coated

Drug Class: Miscellaneous antibiotics

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Important Administration Instructions

•
LAMPIT (30 mg and 120 mg) tablets are for oral use and must be taken with food.
•
LAMPIT tablets are dosed by body weight of the patient [see Dosage and Administration (2.2)].
•
LAMPIT (30 mg and 120 mg) tablets are functionally scored tablets which can be split into one-half (15 mg and 60 mg respectively) at the scored lines by hand. Do not break LAMPIT tablets mechanically with a tablet splitting device [see Dosage and Administration (2.4) and Instructions for Use].
•
LAMPIT 30 mg and 120 mg tablets can be made into a slurry as an alternative method of administration for patients who cannot swallow the tablets [see Dosage and Administration (2.5)].
•
Discontinue consumption of alcohol during treatment with LAMPIT [see Contraindications (4) and Drug Interactions (7)].
•
Complete the full course of treatment to prevent recurrence of the infection.
•
If a dose is missed, take the missed dose as soon as possible together with food. However, if it is within 3 hours of the next scheduled dose, skip the missed dose and continue treatment as prescribed. Do not take a double dose to make up for a missed dose.

Recommended Dosage in Pediatric Patients

•
Administer LAMPIT (30 mg and 120 mg) tablets orally three times a day with food.
•
Total daily recommended dosages of LAMPIT are based on the body weight of the patient (see Table 1).
•
Adjust LAMPIT dosage accordingly if body weight decreases during treatment [see Warnings and Precautions (5.4)].
•
The recommended duration of treatment with LAMPIT is 60 days.

Table 1: Total Daily Recommended Dosages of LAMPIT Based on Body Weight

Age

Body weight group

Total daily dose of nifurtimox (mg/kg)

Birtha to less than 18 years

41 kg or greater

8 to 10

Less than 41 kg

10 to 20

aTerm newborn with body weight of greater than or equal to 2.5 kg

Table 2: Individual Dosages Based on Body Weight in Pediatric Patients (Birtha to Less than 18 years of age)

Body weight (kg)

Dose (mg)

Number of LAMPIT 30 mg tablets per dose
(3 x Daily)

Number of LAMPIT
120 mg tablets per dose
(3 x Daily)

2.5 kg to 4.5 kg

15 mg

½ tablet

—

4.6 kg to less than 9 kg

30 mg

1 tablet

—

9 kg to less than 13 kg

45 mg

1 ½ tablets

—

13 kg to less than 18 kg

60 mg

2 tablets

½ tablet

18 kg to less than 22 kg

75 mg

2 ½ tablets

—

22 kg to less than 27 kg

90 mg

3 tablets

—

27 kg to less than 35 kg

120 mg

4 tablets

1 tablet

35 kg to less than 41 kg

180 mg

—

1 ½ tablets

41 kg to less than 51 kg

120 mg

—

1 tablet

51 kg to less than 71 kg

180 mg

—

1 ½ tablets

71 kg to less than 91 kg

240 mg

—

2 tablets

91 kg or greater

300 mg

—

2 ½ tablets

aTerm newborn with body weight of greater than or equal to 2.5 kg

Pregnancy Testing Prior to Initiating LAMPIT

Obtain a pregnancy test in females of reproductive potential prior to initiating treatment with LAMPIT [see Warnings and Precautions (5.2) and Use in Specific Populations (8.3)].

Instructions for Splitting LAMPIT Tablets

Do not break LAMPIT tablets mechanically with a tablet splitting device. A functional score line is used to divide the tablet by hand as follows:

•
To split LAMPIT tablet, place the tablet on a flat surface with the score line facing up.
•
With the tablet resting on the flat surface, apply enough downward pressure with the index finger centered on the top of the tablet to break it along the score line.

Preparation of a Slurry of LAMPIT as an Alternate Method of Administration

For patients who are unable to swallow whole or half tablets, LAMPIT tablet can be dispersed in water and administered as outlined below.

•
Place approximately 2.5 mL of water into a spoon.
•
Place the prescribed dose into the water.
•
Allow the tablet(s) to disintegrate (typically less than 30 seconds).
•
A slurry (liquid suspension) is formed.
•
Take the slurry immediately with food.
Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by